Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
TB HIV Care, Durban, South Africa.
PLoS One. 2022 Mar 15;17(3):e0265434. doi: 10.1371/journal.pone.0265434. eCollection 2022.
Despite the established efficacy of PrEP to prevent HIV and the advantages of a user-controlled method, PrEP uptake and persistence by women in both trials and demonstration projects has been suboptimal. We utilized real-world data from an HIV service provider to describe persistence on oral PrEP among female sex workers (FSW) in eThekwini, South Africa.
We examined time from PrEP initiation to discontinuation among all FSW initiating PrEP at TB HIV Care in eThekwini between 2016-2020. We used a discrete time-to-event data setup and stacked cumulative incidence function plots, displaying the competing risks of 1) not returning for PrEP, 2) client discontinuation, and 3) provider discontinuation. We calculated hazard ratios using complementary log-log regression and sub-hazard ratios using competing risks regression.
The number of initiations increased each year from 155 (9.3%, n = 155/1659) in 2016 to 1224 (27.5%, n = 1224/4446) in 2020. Persistence 1-month after initiation was 53% (95% CI: 51%-55%). Younger women were more likely to discontinue PrEP by not returning compared with those 25 years and older. Risk of discontinuation through non-return declined for those initiating in later years. Despite the COVID-19 pandemic, a greater number of initiations and sustained persistence were observed in 2020.
Low levels of PrEP persistence were observed, consistent with data among underserved women elsewhere. Encouragingly, the proportion of women persisting increased over time, even as the number of women newly initiating PrEP and staff workload increased. Further research is needed to understand which implementation strategies the program may have enacted to facilitate these improvements and what further changes may be necessary.
尽管已证实 PrEP 可有效预防 HIV,且这种方法由使用者自行控制具有优势,但临床试验和示范项目中女性对 PrEP 的接受度和持续使用情况仍不理想。我们利用一家艾滋病毒服务提供商的真实数据,描述了南非埃滕哈赫市女性性工作者 (FSW) 使用口服 PrEP 的持续情况。
我们调查了 2016 年至 2020 年间在埃滕哈赫 TB HIV 护理中心开始使用 PrEP 的所有 FSW 中,从开始 PrEP 到停药的时间。我们使用离散时间事件数据设置和堆叠累积发生率图,显示了 1) 未返回继续接受 PrEP、2) 客户停药和 3) 提供者停药的竞争风险。我们使用互补对数 - 对数回归计算危险比,使用竞争风险回归计算亚危险比。
每年开始接受 PrEP 的人数都在增加,从 2016 年的 155 人(9.3%,n = 155/1659)增加到 2020 年的 1224 人(27.5%,n = 1224/4446)。起始后 1 个月的持续率为 53%(95%CI:51%-55%)。与 25 岁及以上的女性相比,年轻女性不返回继续接受 PrEP 的可能性更高。起始后,通过不返回而停药的风险随着时间的推移而降低。尽管发生了 COVID-19 大流行,但 2020 年接受 PrEP 的人数和持续率都有所增加。
观察到 PrEP 的持续率较低,这与其他服务不足的女性的数据一致。令人鼓舞的是,随着新开始接受 PrEP 的女性人数和工作人员工作量的增加,持续使用 PrEP 的女性比例也在增加。需要进一步研究以了解该项目可能实施了哪些实施策略来促进这些改进,以及还需要进行哪些进一步的改变。